Adipose-derived Mesenchymal Stem Cells are Ideal for the Cell-based Treatment of Refractory Wounds: Strong Potential for Angiogenesis

Cao, Yingxuan1,2,3; Yan, Jianxin1,2,3; Dong, Zhiqin1,2,3; Wang, Jingru4; Jiang, Xiao1,2,3; Cui, Taixing5; Huang, Yuesheng6; Liu, Hongwei1,2,3

2023-10-01

10.1007/s12015-023-10641-y

STEM CELL REVIEWS AND REPORTS   Impact Factor & Quartile

2629-3269

2629-3277

Although Mesenchymal Stem Cells (MSCs)-based therapy has been proposed as a promising strategy for the treatment of chronic lower-extremity ulcers, their optimal sources, amounts, and delivery methods are urgently needed to be determined. In this study, we compared the heterogeneity of the human MSCs derived from bone marrow (BMSCs), umbilical cord (UCMSCs), and adipose tissue (ADSCs) in accelerating wound healing and promoting angiogenesis and explored the underlying mechanism. Briefly, a diabetic rat model with a full-thickness cutaneous wound on the dorsal foot was developed. The wound was topically administered with three types of MSCs. Additionally, we carried out in vitro and in vivo analysis of the angiogenic properties of the MSCs. Moreover, the molecular mechanism of the heterogeneity of the MSCs derived from the three tissues was explored by transcriptome sequencing. When compared with the BMSCs- and UCMSCs-treated groups, the ADSCs-treated group exhibited markedly accelerated healing efficiency, characterized by increased wound closure rates, enhanced angiogenesis, and collagen deposition at the wound site. The three types of MSCs formed three-dimensional capillary-like structures and promoted angiogenesis in vitro and in vivo, with ADSCs exhibiting the highest capacity for tube formation and pro-angiogenesis. Furthermore, transcriptome sequencing revealed that ADSCs had higher expression levels of angiogenesis-associated genes. Our findings indicate that MSCs-based therapy accelerates the healing of ischemia- and diabetes-induced lower-extremity ulcers and that adipose tissue-derived MSCs might be ideal for therapeutic angiogenesis and treatment of chronic ischemic wounds.

Mesenchymal stem Cells Wound Healing Angiogenesis Bone Marrow Umbilical cord Adipose Tissue

SCI

English

Corresponding

Cell Biology ; Research & Experimental Medicine

Cell & Tissue Engineering ; Cell Biology ; Medicine, Research & Experimental

WOS:001087976000001

SPRINGER

Web of Science

1.Jinan Univ, Affiliated Hosp 1, Dept Plast Surg, Guangzhou 510630, Peoples R China
2.Innovat Technol Res Inst Plast Surg, Guangzhou 510630, Peoples R China
3.Minist Educ, Key Lab Regenerat Med, Guangzhou 510632, Peoples R China
4.First Peoples Hosp Foshan, Dept Burn Surg, Foshan 528000, Peoples R China
5.Univ Missouri, Sch Med, Dalton Cardiovasc Res Ctr, Dept Med Pharmacol & Physiol, Columbia, MO 65211 USA
6.Southern Univ Sci & Technol, Southern Univ Sci & Technol Hosp, Inst Wound Repair & Regenerat Med, Sch Med,Dept Wound Repair, Shenzhen 518055, Peoples R China

Cao, Yingxuan,Yan, Jianxin,Dong, Zhiqin,et al. Adipose-derived Mesenchymal Stem Cells are Ideal for the Cell-based Treatment of Refractory Wounds: Strong Potential for Angiogenesis[J]. STEM CELL REVIEWS AND REPORTS,2023.

Cao, Yingxuan.,Yan, Jianxin.,Dong, Zhiqin.,Wang, Jingru.,Jiang, Xiao.,...&Liu, Hongwei.(2023).Adipose-derived Mesenchymal Stem Cells are Ideal for the Cell-based Treatment of Refractory Wounds: Strong Potential for Angiogenesis.STEM CELL REVIEWS AND REPORTS.

Cao, Yingxuan,et al."Adipose-derived Mesenchymal Stem Cells are Ideal for the Cell-based Treatment of Refractory Wounds: Strong Potential for Angiogenesis".STEM CELL REVIEWS AND REPORTS (2023).